Mavyret and Vosevi added to uninsured formulary, Open Enrollment 2018 information available
LA HAP Bulletin for 11/1/17 Mavyret, Vosevi added to LA HAP uninsured/Medicaid formulary Two medications for the treatment of Hepatitis C, Mavyret (glecaprevir 100mg / pibrentasvir 40mg) and Vosevi (sofosbuvir 400mg / velpatasvir 100mg / voxilaprevir 100mg) have...
Read moreUpcoming LA HAP Open Enrollment webinars, Medicare Open Enrollment, early recertification packets, CareCredit cards
LA HAP Bulletin for 10/12/17 LA HAP Open Enrollment Webinars Next Week All case managers and other assisters who work with LA HAP clients should participate in our Open Enrollment 2018 Webinar, which will be offered on Monday...
Read moreUpdated documentation requirements for HCV-infected LA HAP/Medicaid clients, documenting payments for past-due premiums
LA HAP Bulletin for 9/29/17 Revised documentation requirements for LA HAP/Medicaid Hepatitis C subprogram recipients As we continue conversations with Medicaid, Ramsell, medical providers and HRSA around Hepatitis C medication access, we have determined that we are able...
Read moreClarification on LA HAP coverage of dental and vision services
LA HAP Bulletin for 6-21-17 (updated 7-25-17 and 1-3-19) Clarification on LA HAP coverage of dental and vision services This Bulletin seeks to clarify LA HAP’s scope of coverage regarding dental and vision services. Please contact Alicia at 504-568-5489...
Read more